The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.
Cancer: Inappropriate Expression of Stem Cell Programs?
We Contain Multitudes: The Protean Face of Retinoblastoma
“Atypical” Regulation of Hedgehog-Dependent Cancers
IKKα at the Crossroads of Inflammation and Metastasis
A Pro-metastatic tRNA Pathway
Warren S. Pear, M. Celeste Simon  Cancer Cell 
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
Metastasis gets site specific
Accelerating drug discovery: Open source cancer cell biology?
PI3K Regulatory Subunits Lose Control in Cancer
Volume 9, Issue 6, Pages (June 2006)
Volume 13, Issue 1, Pages 5-6 (January 2011)
A Mitochondrial Power Play in Lymphoma
Three Down and One To Go: Modeling Medulloblastoma Subgroups
Killing Tumors by Keeping Ras and PI3′ Kinase Apart
Tumor Evolution: A Problem of Histocompatibility
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
MDS Is a Stem Cell Disorder After All
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
DAISY: Picking Synthetic Lethals from Cancer Genomes
IKKα at the Crossroads of Inflammation and Metastasis
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
Eun-Jung Jung, George A. Calin  Cancer Cell 
The Wind God Promotes Lung Cancer
Volume 13, Issue 1, Pages 1-2 (January 2008)
A Radical Role for p38 MAPK in Tumor Initiation
Volume 9, Issue 6, Pages (June 2006)
Volume 13, Issue 1, Pages 5-6 (January 2011)
MicroRNAs and Parallel Stem Cell Lives
A MENage à Trois in Leukemia
Inflammation Joins the “Niche”
Looking Back: Cancer Stem Cells
The RAF Inhibitor Paradox Revisited
An Integrin-Linked Machinery of Cytoskeletal Regulation that Enables Experimental Tumor Initiation and Metastatic Colonization  Tsukasa Shibue, Mary W.
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Volume 14, Issue 4, Pages (October 2008)
Volume 16, Issue 3, Pages (September 2009)
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
A common pathway for genetic events leading to pheochromocytoma
Pregnancy and breast cancer: The other side of the coin
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
Volume 54, Issue 5, Pages (June 2014)
All Roads Lead to the Ribosome
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
There's a Time and a Place for MYCN
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Volume 17, Issue 2, Pages (February 2010)
Helge Großhans, Ingo Büssing  Cancer Cell 
Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX  Jean-Christophe Marine  Cancer Cell  Volume.
Looking Back: Cancer Stem Cells
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
The Role of TET2 in Hematologic Neoplasms
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty? Kornelia Polyak  Cancer Cell  Volume 10, Issue 5, Pages 352-354 (November 2006) DOI: 10.1016/j.ccr.2006.10.015 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Model depicting the MEN1-p27Kip1 tumor suppressor pathway In normal cells menin is part of a protein complex responsible for histone H3 lysine 4 methylation (histone H3 K4met), which is required for the expression of p27Kip1 in certain cell types, including endocrine cells. In MEN1 syndrome, due to mutation in either menin (menin∗) or p27Kip1 (p27Kip1∗) cellular p27Kip1 protein levels decrease resulting in tumor formation. Cancer Cell 2006 10, 352-354DOI: (10.1016/j.ccr.2006.10.015) Copyright © 2006 Elsevier Inc. Terms and Conditions